Events & Presentations

Events & Presentations

Corporate Presentation

Upcoming Events

Past Events

October 01, 2022 at 9:55 AM EDT

Retina Subspecialty Day 2 (for registered attendees)
Section X: Late Breaking Developments, Part II
Oral Presentation

Abstract Title: Ph1/2 AAV5-RPGR (Botaretigene Sparoparvovec) Gene Therapy Trial in RPGR-associated X-linked Retinitis Pigmentosa (XLRP)

Presenter: Dr. Michel Michaelides, Professor of Ophthalmology, UCL Institute of Ophthalmology in Dept. of Genetics

September 28, 2022
This gene therapy company is testing new tech to 'switch off' diabetes and obesity with a pill